Daniel J. Cowley

Flemington Road, 3052
Parkville, VIC, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 24 publications

ARMED: an Australian cohort retrospective observational study to understand motivations for switching and clinical outcomes of individuals switching to dolutegravir/lamivudine.

ARMED: an Australian cohort retrospective observational study to understand motivations for switching and clinical outcomes of individuals switching to dolutegravir/lamivudine.

Journal: Sexual health

Published: February 05, 2026

Neonatal rotavirus vaccine (RV3-BB) immunogenicity and safety in a neonatal and infant administration schedule in Malawi: a randomised, double-blind, four-arm parallel group dose-ranging study.

Neonatal rotavirus vaccine (RV3-BB) immunogenicity and safety in a neonatal and infant administration schedule in Malawi: a randomised, double-blind, four-arm parallel group dose-ranging study.

Journal: The Lancet. Infectious diseases

Published: June 01, 2021

Rotavirus specific maternal antibodies and immune response to RV3-BB rotavirus vaccine in central java and yogyakarta, Indonesia.

Rotavirus specific maternal antibodies and immune response to RV3-BB rotavirus vaccine in central java and yogyakarta, Indonesia.

Journal: Vaccine

Published: August 27, 2019

Australian Rotavirus Surveillance Program: Annual Report, 2017

Australian Rotavirus Surveillance Program: Annual Report, 2017

Journal: Communicable diseases intelligence (2018)

Published: July 18, 2019

Human Neonatal Rotavirus Vaccine (RV3-BB) Produces Vaccine Take Irrespective of Histo-Blood Group Antigen Status.

Human Neonatal Rotavirus Vaccine (RV3-BB) Produces Vaccine Take Irrespective of Histo-Blood Group Antigen Status.

Journal: The Journal of infectious diseases

Published: May 06, 2019

Immunogenicity of four doses of oral poliovirus vaccine when co-administered with the human neonatal rotavirus vaccine (RV3-BB).

Immunogenicity of four doses of oral poliovirus vaccine when co-administered with the human neonatal rotavirus vaccine (RV3-BB).

Journal: Vaccine

Published: April 23, 2019

Serological responses to rotavirus NSP2 following administration of RV3-BB human neonatal rotavirus vaccine.

Serological responses to rotavirus NSP2 following administration of RV3-BB human neonatal rotavirus vaccine.

Journal: Human vaccines & immunotherapeutics

Published: April 25, 2018

Molecular characterisation of rotavirus strains detected during a clinical trial of the human neonatal rotavirus vaccine (RV3-BB) in Indonesia.

Molecular characterisation of rotavirus strains detected during a clinical trial of the human neonatal rotavirus vaccine (RV3-BB) in Indonesia.

Journal: Vaccine

Published: February 22, 2018

Human Neonatal Rotavirus Vaccine (RV3-BB) to Target Rotavirus from Birth.

Human Neonatal Rotavirus Vaccine (RV3-BB) to Target Rotavirus from Birth.

Journal: The New England journal of medicine

Published: February 22, 2018

The Impact of Rotavirus Vaccines on Genotype Diversity: A Comprehensive Analysis of 2 Decades of Australian Surveillance Data.

The Impact of Rotavirus Vaccines on Genotype Diversity: A Comprehensive Analysis of 2 Decades of Australian Surveillance Data.

Journal: The Journal of infectious diseases

Published: December 13, 2017

Rotavirus shedding following administration of RV3-BB human neonatal rotavirus vaccine.

Rotavirus shedding following administration of RV3-BB human neonatal rotavirus vaccine.

Journal: Human vaccines & immunotherapeutics

Published: May 09, 2017

Etiology of Severe Acute Watery Diarrhea in Children in the Global Rotavirus Surveillance Network Using Quantitative Polymerase Chain Reaction.

Etiology of Severe Acute Watery Diarrhea in Children in the Global Rotavirus Surveillance Network Using Quantitative Polymerase Chain Reaction.

Journal: The Journal of infectious diseases

Published: January 19, 2017

Showing 1-12 of 24

Last Updated: 09/26/2026